Clinical Trial Update: ATG Individualized Dosing Model in URD-PBSCT. [Phase 2]

View source ↗

Summary

Phase 2 trial updating an individualized dosing model of antithymocyte globulin in unrelated donor peripheral blood stem cell transplantation, with focus on cyt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• Antithymocyte Globulin (anti-thymocyte globulin)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Cytomegalovirus Infections, Infection Reactivation | Phase 2 | Status: RECRUITING